TP53 and colonic neoplasm: For example, in vitro studies showed that the response to 5-fluorouracil (5-FU)-based chemotherapy is complete only in colon cancer models with wild-type TP53; however, retrospective studies or incorporation of TP53 mutation status in clinical studies could demonstrate the translational value of this dependency [15].